According to Zhitong Finance App, Fosun Pharmaceutical (02196.HK) announced that the drug registration application for venlafaxine hydrochloride sustained-release tablets (hereinafter referred to as the “new drug”) from Fosun Pharmaceutical (Xuzhou) Co., Ltd., the holding subsidiary of the company was recently accepted by the China Drug Administration.

Zhitongcaijing · 10/17 10:09
According to Zhitong Finance App, Fosun Pharmaceutical (02196.HK) announced that the drug registration application for venlafaxine hydrochloride sustained-release tablets (hereinafter referred to as the “new drug”) from Fosun Pharmaceutical (Xuzhou) Co., Ltd., the holding subsidiary of the company was recently accepted by the China Drug Administration.